Prix
Questions fréquentes
Quelle est la capitalisation boursière de Grail ?
Quel est le bénéfice par action (BPA) de Grail ?
Quel est le chiffre d'affaires de Grail sur les douze derniers mois ?
Quel est l'EBITDA de Grail ?
Quel est le flux de trésorerie disponible de Grail ?
Combien d'employés compte Grail, et à quel secteur d'activité appartient-elle ?
Quel est le flottant des actions de Grail ?
Finances
Capitalisation boursière
422,89 M $USBPA (TTM)
-99,94 $USFree Float
26,46 MRecettes (TTM)
109,74 M $USEBITDA (TTM)
-655,90 M $USCash-flow disponible (TTM)
-676,39 M $USCotation
Informations
GRAIL, Inc., formerly GRAIL, LLC, is a healthcare company, which is engaged in saving lives and shifting the paradigm in early cancer detection. It is focused on alleviating the global burden of cancer by using next-generation sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its products include Galleri and Beyond. The Galleri test is a commercially available screening test for early detection of multiple types of cancer, which is termed multi-cancer early detection (MCED). Galleri screening test results can help guide next steps for a diagnosis of cancer by healthcare providers.
1 370
Biotechnology & Drugs
Soins de santé
Identifiant
ISIN
Ticker primaire